ArticleFrontiers in molecular biosciences2021

Efficacy and Safety of Combination Treatment With Apatinib and Osimertinib After Osimertinib Resistance in Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Carcinoma-A Retrospective Analysis of a Multicenter Clinical Study.

Xue Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.